The global bone grafts and substitutes market was worth $3.06 billion. By the end of 2028, sales of bone grafts and substitutes are expected to increase at a CAGR of 4.9% and reach US$ 4.44 billion. The bone grafts and substitutes market refers to the segment of the medical device industry that provides products used in orthopedic and dental procedures to repair and rebuild damaged or missing bones. Bone grafts and substitutes are used in a variety of procedures, including spinal fusion, joint reconstruction, and craniofacial reconstruction.
The market for bone grafts and substitutes includes products such as allografts, synthetic bone grafts, and bone morphogenetic proteins. Key players in the bone grafts and substitutes market include companies such as Medtronic, Stryker, Zimmer Biomet, and DePuy Synthes.
The market for bone grafts and substitutes is anticipated to expand in the upcoming years as a result of an ageing population, rising demand for orthopaedic and dental procedures, and technological developments in medicine. Demand for bone grafts and substitutes is also being fueled by the rising prevalence of osteoporosis and other bone-related diseases.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7229
Key Segments Covered in Bone Grafts and Substitutes Industry Research
- By Product:
- Allografts
- Demineralized Bone Matrix (DBM)
- Others
- Synthetic Bone Grafts
- Others
- Allografts
- By Material:
- Ceramic-based Bone Grafts and Substitutes
- Calcium Phosphate
- Calcium Sulfate
- Others
- Polymer-based Bone Grafts and Substitutes
- Polylactides
- Polyglycolides
- Polyurethanes
- Others
- Growth Factor-based Bone Grafts and Substitutes
- Cell-based Bone Grafts and Substitutes
- Others
- Ceramic-based Bone Grafts and Substitutes
- By End User:
- Hospitals
- Orthopedic Clinics
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Takeaways from Market Study
- Global bone grafts and substitutes market to reach a valuation of US$ 4.44 Bn by 2028.
- Market in North America holds a high share of 53.1%.
- Demand for allografts are expected to increase at a significant CAGR over the coming years.
Winning Strategy
The market is characterized by fierce competition and is dominated by a few important players. To increase revenue, key businesses are focusing on executing creative tactics such as mergers & acquisitions, market penetration, collaborations, and distribution agreements.
Key players in the market are concentrating on diversifying their product portfolios and utilizing materials with higher quality, characteristics, and functionalities.
For instance,
- In February 2021, NuVasive bought Simplify Medical to expand its cervical portfolio and expand growth prospects.
- In 2019, McGill University produced a biocompatible and hardened multilayered bone grafts for the repair of major bone lesions.
- In 2019, Bioventus launched OSTEOMATRIX+, a next-generation biphasic bone transplant for use in orthopedic and spine applications.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global bone grafts and substitutes market, presenting historical demand data (2017-2020) and forecast statistics for the period of 2021-2028.
The study divulges essential insights on the market on the basis of product (allografts, synthetic bone grafts, and others), by material (ceramic-based, polymer-based, growth factor-based, cell-based, and others) by end user (hospitals, orthopedic clinics, and others), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA).
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
